靶血管血运重建相关论文
1969年 ,ＣｈａｒｌｅｓＤｏｔｔｅｒ报道了在犬动脉中植入弹簧线圈状支架的实验结果 ,第一次提出了血管内修复的观点 ,今天支架置入技术已经成为冠状动脉血......
随着对冠心病 (ＣＨＤ)机制认识的不断深入 ,人们提出了急性冠脉综合征 (ＡＣＳ)的概念。它是指由于冠状动脉内斑块破裂、表面破损或出现裂纹 ,......
...
在行经皮冠状动脉介入治疗的糖尿病患者中,abciximab(阿昔单抗)与支架的联合应用已被证明是降低靶血管血运重建(TVR)和死亡率的标......
We investigated whether the observed protective effect of hyperlipidemia is stronger in patients who take statins and, i......
〈WashingtonRadiationforIn StentRestenosisTrial〉是一项双盲、随机化研究,评估用冠状动脉内照射(IRT)治疗支架内狭窄(ISR)。13......
血管内放射治疗法已被证明是对支架置入术后再狭窄有效的疗法,然而该法伴有较高的失败率。该研究用于评估发生支架内再狭窄的患者......
Despite the proven superiority of sirolimus-eluting stents(SESs) compared with bare stents in the first year after impla......
The goal of this study was to determine if restenosis is increased in mild and moderate chronic kidney disease (CKD) pat......
Bare-metal stenting with abciximab pretreatment is currently considered a reasonable reperfusion strategy for acute ST-s......
The aim of this study was to establish safety and feasibility of oral Rapamyci n at two doses -2 mg and 5 mg -in achievi......
Background: The filter-based FilterWire EX(Boston Scientific, Natick, MA) embolic protection system and the GuardWire(Me......
OBJECTIVES: The purpose of this study was to investigate the medium-term(two year) outcome of the unrestricted utilizati......
意大利学者Biondi-Zoccai等的注册研究显示,药物洗脱支架(DES)置入后残留的夹层对患者预后有不良影响。Biondi-Zoccai等在意大利的......
Context: No specifically designed studies have addressed the role of the glycoprotein IIb/IIIa inhibitor abciximab in pa......
Randomized trials have shown that implantation of sirolimus-eluting stents(SESs) and paclitaxel-eluting stents(PESs) red......
Context: Although vascular brachytherapy is the only approved therapy for restenosis following bare-metal stent implanta......
Background: The association between infarct artery location, reperfusion success, and clinical outcomes after primary pe......
RESEARCH(Rapamycin-Eluting Stent Evaluated at RotterdamCardiology Hospital)注册最新公布的中期(2年)研究结果表明,西罗莫司......
Context: Restenosis within bare-metal stents is often treated with repeat percutaneous coronary intervention, although s......
The presence of bundle branch block(BBB) has been associated with poor outcomes in patients who have acute myocardial in......
Objective: To compare clinical outcome of paclitaxel eluting stents(PES) versus sirolimus eluting stents(SES) for the tr......
Context: Compared with bare metal stents, drug-eluting stents reduce restenosis in noncomplex lesions. The utility of dr......
Background:Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal stents, reduce the risk o......
随着介入技术的发展及金属支架的广泛应用,裸金属支架内再狭窄成为当今介入医师最关注及迫切需要解决的问题。血管内放射治疗(VBT)......
Objectives: We hypothesized that a higher degree of inflammatory response to coronary stenting, as measured by the chang......
对介入心脏病医生来说无保护左主干病变的介入治疗始终是一个富有挑战性的难题。尽管目前PCI只是有选择的应用于某些无保护左主干......
美国Douglas等发现,西洛他唑显著降低冠状动脉支架术后再狭窄。CREST为一项随机、双盲、安慰剂对照的临床试验,旨在研究内膜增殖抑......
目的探讨雷帕霉素洗脱支架(SES)在STEMI患者PCI中的疗效及安全性。方法2002年10月至2004年12月112例住院患者,男了4例,女38例,平均......
目的:利用RESEARCH(鹿特丹心脏病医院雷帕霉素洗脱支架评估)注册研究中的非选择性患者,比较以西罗莫司洗脱支架(SES)与裸金属支架(......
越来越多的证据表明阻塞性睡眠呼吸暂停(OSA)与心血管系统发病有关。作者推测,OSA可影响急性冠状动脉综合征(ACS)患者经皮冠状动脉......
意大利学者Corbett等研究认为,尽管不提倡在一支冠脉中置入不同类型的药物洗脱支架,但这种做法依然安全。当无法在同一支冠脉或同......
目的:评价需长期抗凝治疗的患者接受冠状动脉支架置入后的抗血栓形成治疗。方法和结果:回顾性分析了2003—2004年在6家医院接受经......
AMI行PCI时DES、BMS孰优孰劣?PASSION研究和TYPHOON研究结果不尽一致。这两个研究中的AMI都经过了挑选,与之不同,美国学者Kupferwa......
美国学者Javaid等发现,药物洗脱支架(DES)置入术后CK-MB水平达到或超过正常上限的3倍,可以作为复杂冠脉病变及临床治疗欠成功的一......
美国华盛顿医院心脏病学中心Waksman等研究发现,血栓形成仍然是药物洗脱支架的主要问题,而支架类型与血栓发生率有关,西罗莫司洗脱......
目前无选择性地给患者置入雷帕霉素药物洗脱支架(SES)而发生晚期支架内血栓(ST)的现象已经引起业内高度重视。法国学者Machecourt......
美国学者Javaid等研究发现,在2～3支冠脉血管病变的患者中,CABG能降低其MACE发生率,尤其合并糖尿病者。因此,CABG是糖尿病合并多支血......
近来,美国FDA进行的几项关于雷帕霉素洗脱支架(SES)和紫杉醇洗脱支架(PES)的长期安全性的研究显示,与金属裸支架(BMS)相比,药物洗......
